Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr;11(2):119-24.
doi: 10.1007/s11938-008-0024-8.

Endoscopic Submucosal Dissection for Gastric Cancer

Affiliations

Endoscopic Submucosal Dissection for Gastric Cancer

Mitsuhiro Fujishiro. Curr Treat Options Gastroenterol. .

Abstract

Endoscopic submucosal dissection (ESD) is a novel endoscopic treatment that enables a clinician to resect an early-stage gastric cancer in en bloc fashion. ESD is indicated for those cancers in which there is a high probability of en bloc resection and low probability of lymph node metastasis. The latter may be the limiting factor at institutions skilled at ESD. Several ESD techniques are available with similar outcomes. Thus, selection depends on operator preference and expertise. Gastrectomy with lymphadenectomy should be applied initially to those early gastric cancers with high probability of positive lymph nodes or as an additional treatment after ESD. Endoscopic mucosal resection (EMR) should be reserved for small, nonulcerated, intramucosal, differentiated cancers. Disadvantages of ESD in comparison with EMR are longer operation times and higher incidences of intraoperative bleeding and perforation, but the indication for ESD includes larger and ulcerative lesions not amenable to EMR.

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles

References

    1. Gastrointest Endosc. 2006 Feb;63(2):243-9 - PubMed
    1. Gut. 2003 Mar;52(3):334-9 - PubMed
    1. World J Gastroenterol. 2006 Aug 28;12(32):5108-12 - PubMed
    1. Gastrointest Endosc. 2006 Dec;64(6):877-83 - PubMed
    1. Gastrointest Endosc. 1993 Jan-Feb;39(1):58-62 - PubMed

LinkOut - more resources

Feedback